TCGA and tissue microanalysis indicated the significant over-expression of PHF5A in cancer cell lines upon investigation of the clinical and biological performance of PHF5A in NSCLC (non-small cell lung cancer) [49]. This evidence concerns the gene PHF5A and non-small cell lung carcinoma.